Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

NCT03883776 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

DRUG: Al18F-NOTA-octreotide
DEVICE: PET/CT
OTHER: Venous blood samples

Sponsor

Universitaire Ziekenhuizen KU Leuven